SynVivo, Inc
Biotechnology ResearchAlabama, United States2-10 Employees
SynVivo is a 3D Tissue and Organ-on-Chip developer whose models accelerate real-time studies of cellular behavior, drug delivery, and drug discovery by providing a biologically realistic microenvironment that more accurately depicts in vivo reality. SynVivo's models recreate complex in vivo microvasculature including scale, morphology, hemodynamic shear stress, and cellular interactions in an in vitro microfluidic chip environment and enable real-time visualization and quantitation. SynVivo's proprietary microfluidic technology links the high-tech domains of microfluidics and bioengineering for broad applications in the life science arena. SynVivo microfluidic chips mimic the microvascular environment for culturing cells that retain many of the features found in human tissues and organs. This microfluidic platform has the potential to be a game-changer for diseases like cancer as it enables the use of cells from patient biopsies to replicate the tumor environment for testing the efficacy of drugs or drug combinations—thus providing a novel personalized medicine approach to cancer therapy.